Mergers & Acquisitions - Mergers & Acquisitions, Generics, Respiratory and Pulmonary

Briefs: Bidding war for Obagi escalates, as Valeant ups offer; AstraZeneca plans to sue Actavis

03-04-2013

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) today (April 3) announced…

ActavisAstraZenecaDermatologicalsGenericsLegalMergers & AcquisitionsMerz PharmaceuticalsObagi Medical ProductsPharmaceuticalPulmicort RespulesRespiratory and PulmonaryValeant Pharmaceuticals

Company Spotlight

ImmunoGen

ImmunoGen

Back to top